Study to Assess Adverse Events and Compare How Two Subcutaneous ABBV-154 Injection Formulations Move Through the Body of Adult Healthy Participants
Clinical trial NCT05556226 · COMPLETED
Trial details
- NCT number
- NCT05556226
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-18
- Primary completion
- 2023-02-17
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.